. Author manuscript; available in PMC: 2014 Sep 15.

Published in final edited form as: Cochrane Database Syst Rev. 2007 Oct 17;(4):CD003794. doi: 10.1002/14651858.CD003794.pub3

Analysis 2.34. Comparison 2 Fluticasone/salmeterol (FPS) versus placebo (PLA), Outcome 34 Adverse events - hoarseness.

Review: Combined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease

Comparison: 2 Fluticasone/salmeterol (FPS) versus placebo (PLA)

Outcome: 34 Adverse events - hoarseness